Raju V. Pusapati
19 works · 955 citations · h-index 9
Top works
- Acquired Resistance of Non–Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency
- ATM promotes apoptosis and suppresses tumorigenesis in response to Myc
- Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition
- mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells
- Oncogenes and the DNA Damage Response: Myc and E2F1 Engage the ATM Signaling Pathway to Activate p53 and Induce Apoptosis
- E2F2 suppresses Myc‐induced proliferation and tumorigenesis
- Hepatitis B vaccination in premature and low birth weight (LBW) babies.
- Transgenic expression of E2F3a causes DNA damage leading to ATM-dependent apoptosis
- Drug resistance in glioblastoma: Challenges, mechanisms and therapeutic strategies (Review)
- TORquing metabolic reprogramming in cancer cells
- Data from Acquired Resistance of Non–Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency
- Supplementary Figures 1-5 from Acquired Resistance of Non–Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency
- Supplementary Figure and Table Legends 1-5 from Acquired Resistance of Non–Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency
- Data from Acquired Resistance of Non–Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency
- Supplementary Figure and Table Legends 1-5 from Acquired Resistance of Non–Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency
- Abstract B02: mTOR/S6K pathway-dependent metabolic reprogramming in cancer cells mediates resistance to glycolytic inhibitors
- Supplementary Figures 1-5 from Acquired Resistance of Non–Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency
- Supplementary Tables 1-5 from Acquired Resistance of Non–Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency
- Supplementary Tables 1-5 from Acquired Resistance of Non–Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency